Innovative application of allosteric modulators of adenosine a1 receptors for the prevention and treatment of stroke and myocardial infarction

Informazioni relative al progetto

KOUROUNAKIS ANGELIKI

ID dell’accordo di sovvenzione: QLK6-CT-1999-51170

Progetto chiuso

Data di avvio 17 Gennaio 2000

Data di completamento 16 Gennaio 2001

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 51 600,00

Contributo UE € 51 600,00

Coordinato da

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece

Obiettivo

Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.

Campo scientifico

• medical and health sciences › basic medicine › neurology › stroke

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

ARISTOTLE UNIVERSITY OF THESSALONIKI

• Contributo UE: Nessun dato
• Indirizzo: University Building Administration Building ; 54006 THESSALONKI ; Grecia
• Costo totale: Nessun dato